Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Boursier, Jérôme ^a,b   Bertrais, Sandrine ^b   Oberti, Frédéric ^a,b   Gallois, Yves ^a,b   Fouchard Hubert, Isabelle ^a,b   Rousselet, Marie Christine ^a,b   Zarski, Jean Pierre ^c   Calès, Paul ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; ELASTOGRAPHY; EQUIPMENT; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; METAVIR FIBROSIS STAGING; NON INVASIVE MEASUREMENT; REPRODUCIBILITY; STAGING; VALIDATION STUDY; BIOPSY; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; LIVER; LIVER CIRRHOSIS; PATHOLOGY;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; BIOPSY; ELASTICITY IMAGING TECHNIQUES; HEMATOLOGIC TESTS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; REPRODUCIBILITY OF RESULTS;

EID: 82255173789     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-132     Document Type: Article

References (25)

1. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994, 20(1 Pt 1):15-20.
2. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22(6):696-699. 10.1016/0168-8278(95)80226-6, 7560864.
3. Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE, Ghany MG, Mills AS, Nash SR, Govindarajan S, et al. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 2010, 51(2):585-594. 10.1002/hep.23315, 20101752.
4. Leroy V, Halfon P, Bacq Y, Boursier J, Rousselet MC, Bourliere M, de Muret A, Sturm N, Hunault G, Penaranda G, et al. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data. Clin Biochem 2008, 41(16-17):1368-1376. 10.1016/j.clinbiochem.2008.06.020, 18655779.
5. Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004, 3(1):8. 10.1186/1476-5926-3-8, 522750, 15387887.
6. de Ledinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol 2008, 32(6 Suppl 1):58-67.
7. Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, Bower M, Gazzard B, Nelson M. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 2010, 44(3):214-219. 10.1097/MCG.0b013e3181b4af1f, 19745758.
8. Cales P, Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, Dib N, Zarski JP, Rousselet MC. Optimization and robustness of blood tests for liver fibrosis and cirrhosis. Clin Biochem 2010, 43(16-17):1315-1322. 10.1016/j.clinbiochem.2010.08.010, 20713037.
9. Rousselet MC, Michalak S, Dupre F, Croue A, Bedossa P, Saint-Andre JP, Cales P. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005, 41(2):257-264. 10.1002/hep.20535, 15660389.
10. Halfon P, Bacq Y, De Muret A, Penaranda G, Bourliere M, Ouzan D, Tran A, Botta D, Renou C, Brechot MC, et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 2007, 46(3):395-402. 10.1016/j.jhep.2006.09.020, 17156890.
11. Cales P, de Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, Foucher J, Bourliere M, de Muret A, Sturm N, et al. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int 2008, 28(10):1352-1362. 10.1111/j.1478-3231.2008.01789.x, 2711538, 18492022.
12. Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, Boisson RC, Bosson JL, Guyader D, Renversez JC, et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study. J Hepatol 2011,
13. Boursier J, de Ledinghen V, Zarski JP, Rousselet MC, Sturm N, Foucher J, Leroy V, Fouchard-Hubert I, Bertrais S, Gallois Y, et al. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol 2011, 106(7):1255-1263. 10.1038/ajg.2011.100, 21468012.
14. Cales P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konate A, Gallois Y, Ternisien C, Chevailler A, Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005, 42(6):1373-1381. 10.1002/hep.20935, 16317693.
15. Boursier J, Vergniol J, Sawadogo A, Dakka T, Michalak S, Gallois Y, Le Tallec V, Oberti F, Fouchard-Hubert I, Dib N, et al. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int 2009, 29(10):1507-1515. 10.1111/j.1478-3231.2009.02101.x, 19725892.
16. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HCW, Lijmer JG. The STARD statement for reporting studies of diagnostic acuracy: explanation and elaboration. Clin Chem 2003, 49(1):7-18. 10.1373/49.1.7, 12507954.
17. Mayo MJ, Parkes J, Adams-Huet B, Combes B, Mills AS, Markin RS, Rubin R, Wheeler D, Contos M, West AB, et al. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology 2008, 48(5):1549-1557. 10.1002/hep.22517, 2597274, 18846542.
18. Naveau S, Gaude G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prevot S, Ngo Y, Munteanu M, et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009, 49(1):97-105. 10.1002/hep.22576, 19053048.
19. Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol 2009, 50(1):1-3.
20. Gressner OA, Beer N, Jodlowski A, Gressner AM. Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis. Clin Chim Acta 2009, 409(1-2):90-95. 10.1016/j.cca.2009.09.005, 19748500.
21. Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol 2009, 50(1):36-41. 10.1016/j.jhep.2008.07.039, 2637134, 19012989.
22. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, Messous D, Thibault V, Benhamou Y, Moussalli J, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004, 50(8):1344-1355. 10.1373/clinchem.2004.032227, 15192028.
23. Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, Portal I, Allemand I, Bertrand JJ, Rosenthal-Allieri A, et al. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol 2006, 101(3):547-555. 10.1111/j.1572-0241.2006.00411.x, 16542291.
24. Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 2008, 48(2):418-431. 10.1002/hep.22375, 18563841.
25. Boursier J, Isselin G, Fouchard-Hubert I, Oberti F, Dib N, Lebigot J, Bertrais S, Gallois Y, Cales P, Aube C. Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur J Gastroenterol Hepatol 2010, 22(9):1074-1084. 10.1097/MEG.0b013e328339e0a1, 20440210.